OBJECTIVE. The purpose of this article is to determine the upgrade rate to ductal carcinoma
in situ (DCIS) or invasive carcinoma at excision at the same site after percutaneous breast …

Purpose To assess the utility of precise radiologic and pathologic correlation for establishing
imaging-histologic concordance or discordance as a method to limit the number of patients …

Purpose Controversy surrounds management of lobular neoplasia (LN),[atypical lobular
hyperplasia (ALH) or lobular carcinoma in situ (LCIS)], diagnosed on core needle biopsy …

Objective To determine upgrade rates of lobular neoplasia (LN) to malignancy and evaluate
factors that may predict upgrade. Methods From 5/1/2003 to 12/30/2015, breast lesions …

BACKGROUND: No consensus exists on the need to excise breast lesions that yield classic
lobular carcinoma in situ (LCIS) or atypical lobular hyperplasia (ALH)(known together as …

OBJECTIVE. The aims of our study were to determine the frequency of malignancy after
surgical excision of biopsy-proven lobular carcinoma in situ (LCIS) or atypical lobular …

Lobular neoplasia including lobular carcinoma in situ (LCIS) and atypical lobular
hyperplasia (ALH) may be identified in breast core needle biopsies as incidental findings or …

Lobular neoplasia (LN) involves proliferative changes within the breast lobules. LN is
divided into lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH). LCIS …

Management of classic lobular neoplasia (cLN) diagnosed on core needle biopsy (CNB) is
controversial. Our aim in this study was to review cases of cLN diagnosed on CNB to …

Background Management recommendations for lobular neoplasia (LN) including lobular
carcinoma-in-situ (LCIS) and atypical lobular hyperplasia (ALH) diagnosed in core biopsies …